STOCK TITAN

Enovis (ENOV) director has 3,059 shares withheld for RSU taxes

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Enovis CORP director Shirley Brady reported a tax-related share disposition. On March 4, 2026, 3,059 shares of Enovis common stock at $25.79 per share were withheld by the company to satisfy tax withholding obligations tied to restricted stock units.

The footnote explains this was not an open-market sale by Brady but a tax-withholding disposition in connection with net settlement of RSUs. After this transaction, Brady directly owned 101,243 Enovis shares.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Shirley Brady

(Last) (First) (Middle)
2711 CENTERVILLE ROAD
SUITE 400

(Street)
WILMINGTON DE 19808

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Enovis CORP [ ENOV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock, par value $0.001 03/04/2026 F 3,059(1) D $25.79 101,243 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares that have been withheld by the Company to satisfy tax withholding and remittance obligations in connection with the net settlement of restricted stock units and does not represent a sale by the reporting person.
/s/ Brian P. Hanigan, attorney-in-fact 03/06/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Enovis (ENOV) director Shirley Brady report in this Form 4?

Enovis director Shirley Brady reported that 3,059 shares of common stock were withheld by the company to cover tax obligations from restricted stock units, a routine tax-withholding disposition rather than a voluntary open-market sale.

How many Enovis (ENOV) shares were involved in Shirley Brady’s tax withholding?

The filing shows 3,059 Enovis common shares were withheld by the company at $25.79 per share to satisfy tax withholding and remittance obligations arising from the net settlement of restricted stock units awarded to Shirley Brady.

Was Shirley Brady’s Enovis (ENOV) Form 4 transaction an open-market sale?

No, the Form 4 footnote states the 3,059 shares represent stock withheld by Enovis to satisfy tax withholding on restricted stock units and explicitly notes this does not represent a sale by the reporting person in the market.

How many Enovis (ENOV) shares does Shirley Brady own after this Form 4 transaction?

After the tax-withholding disposition, Shirley Brady directly owns 101,243 shares of Enovis common stock. This balance reflects her holdings following the company’s withholding of 3,059 shares to meet related restricted stock unit tax obligations.

What does transaction code F mean in Shirley Brady’s Enovis (ENOV) Form 4?

Transaction code F indicates a tax-withholding disposition, where shares are delivered or withheld to pay exercise price or tax liabilities. In this case, Enovis withheld 3,059 shares from Shirley Brady’s restricted stock units to cover associated tax obligations.
Enovis Corp

NYSE:ENOV

ENOV Rankings

ENOV Latest News

ENOV Latest SEC Filings

ENOV Stock Data

1.39B
55.86M
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
WILMINGTON